Skip to Content
Silicon Valley

Uber and Lyft are behind a sharp rise in US traffic deaths

October 25, 2018

The rise of ride-sharing services has increased traffic deaths by 2% to 3% in the US since 2011, equivalent to as many as 1,100 mortalities a year, according to a new study from the University of Chicago and Rice University.

How it was calculated: Researchers took statistics from the National Highway Traffic Safety Administration and compared them with the dates Uber or Lyft launched in a specific city. Then they checked accident rates in those cities relative to vehicle miles traveled. That rate shot up in San Francisco after Uber launched in 2010, a phenomenon that was replicated in other cities.

Deadheading: The increase in congestion is partly because drivers spend 40% to 60% of their time searching for passengers, a practice known as “deadheading.” On average, drivers in New York City traveled 2.8 miles between fares.

Before ride-sharing: Traffic deaths fell to their lowest number just before Uber launched in San Francisco. In 2010 there were 32,885 fatal car accidents nationwide, the lowest number since 1949. This decline halted and then reversed after the introduction of ride-sharing in US cities. However, it “may be too soon to tell whether the effect we document is a short-term adjustment or a longer-term pattern,” the researchers said.

Piling up problems: The study adds to a growing body of research on ride-sharing companies. Recent studies have found they increase congestion and cut the use of public transport. Cities are starting to respond to harms, perceived or otherwise. New York’s city council introduced a cap on ride-sharing in August, for example.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.